Cadonilimab in combined with gemcitabine and cisplatin in advanced biliary tract cancer (BicureX): A phase II, single-arm clinical trial.

被引：0
|
作者：
Ma, Ji
Wang, Tao
Chen, Yidi
Yang, Yi
Qiu, Yiwen
Shen, Shu
Yi, Cheng
Wang, Wentao
机构：
[1] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16158
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cadonilimab plus lenvatinib in patients with advanced endometrial cancer: A multicenter, single-arm, phase II trial.
    Lan, Chunyan
    Yang, Xielan
    Zhao, Jing
    Zheng, Min
    Yang, Fan
    Xie, Zhiwen
    Wu, Xiaoliu
    Yang, Hongying
    Wang, Wenyan
    Huang, Xin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer
    D. Ferraro
    D. Goldstein
    R. L. O’Connell
    J. R. Zalcberg
    K. M. Sjoquist
    N. C. Tebbutt
    P. Grimison
    S. McLachlan
    L. L. Lipton
    P. Vasey
    V. J. Gebski
    C. Aiken
    M. Cronk
    S. Ng
    C. S. Karapetis
    J. Shannon
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 361 - 367
  • [3] TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer
    Ferraro, D.
    Goldstein, D.
    O'Connell, R. L.
    Zalcberg, J. R.
    Sjoquist, K. M.
    Tebbutt, N. C.
    Grimison, P.
    McLachlan, S.
    Lipton, L. L.
    Vasey, P.
    Gebski, V. J.
    Aiken, C.
    Cronk, M.
    Ng, S.
    Karapetis, C. S.
    Shannon, J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (02) : 361 - 367
  • [4] Gemcitabine and cisplatin or oxaliplatin chemotherapy combined with atezolizumab plus bevacizumab for advanced biliary tract cancers: a single-arm trial
    Wang, Kang
    Yu, Hong-Ming
    Xiang, Yan-Jun
    Cheng, Yu-Qiang
    Ni, Qian-Zhi
    Guo, Wei-Xing
    Shi, Jie
    Feng, Shuang
    Zhai, Jian
    Cheng, Shu-Qun
    FUTURE ONCOLOGY, 2023, 19 (15) : 1029 - 1035
  • [5] A Single-Arm Phase II Study of Nab-Paclitaxel Plus Gemcitabine and Cisplatin for Locally Advanced or Metastatic Biliary Tract Cancer
    Liu, Ting
    Li, Qing
    Lin, Zhen
    Liu, Chunhua
    Pu, Wei
    Zeng, Shasha
    Lai, Jun
    Cai, Xuebin
    Zhang, Lisha
    Wang, Shuyang
    Chen, Miao
    Cao, Wei
    Gou, Hongfeng
    Zhu, Qing
    CANCER RESEARCH AND TREATMENT, 2024, 56 (02): : 602 - 615
  • [6] A single-arm phase II trial of gemcitabine, oxaliplatin, and panitumumab in KRAS wild-type advanced biliary tract cancer
    Noel, Marcus Smith
    Allen, Jill N.
    Abrams, Thomas Adam
    Yurgelun, Matthew
    Faris, Jason Edward
    Goyal, Lipika
    Clark, Jeffrey W.
    Blaszkowsky, Lawrence Scott
    Murphy, Janet E.
    Zheng, Hui
    Khorana, Alok A.
    Connolly, Gregory Clayton
    Hyrien, Ollivier
    Ng, Kimmie
    Borger, Darrell R.
    Iafrate, Anthony John
    Hezel, Aram F.
    Zhu, Andrew X.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [7] Efficacy and safety of FOLFIRINOX in advanced biliary tract cancer after failure of gemcitabine plus cisplatin: A phase II trial.
    Belkouz, Ali
    de Vos-Geelen, Judith
    Eskens, Ferry
    Mathot, Ron A. A.
    van Gulik, Thomas
    van Oijen, Martijn G. H.
    Punt, Cornelis J. A.
    Wilmink, Johanna
    Kluempen, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer
    Park, Byung Kyu
    Kim, Yoon Jae
    Park, Jeong Youp
    Bang, Seungmin
    Park, Seung Woo
    Chung, Jae Bock
    Kim, Kyung Sik
    Choi, Jin-Sub
    Lee, Woo Jung
    Song, Si Young
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (06) : 999 - 1003
  • [9] A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer
    Kim, ST
    Park, JO
    Lee, J
    Lee, KT
    Lee, JK
    Choi, SH
    Heo, JS
    Park, YS
    Kang, WK
    Park, K
    CANCER, 2006, 106 (06) : 1339 - 1346
  • [10] Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial
    Chen, Xiaofeng
    Wu, Xiaofeng
    Wu, Hao
    Gu, Yanhong
    Shao, Yang
    Shao, Qianwen
    Zhu, Feipeng
    Li, Xiao
    Qian, Xiaofeng
    Hu, Jun
    Zhao, Fengjiao
    Mao, Weidong
    Sun, Jing
    Wang, Jian
    Han, Gaohua
    Li, Changxian
    Xia, Yongxiang
    Seesaha, Poshita Kumari
    Zhu, Dongqin
    Li, Huajun
    Zhang, Junling
    Wang, Guoqiang
    Wang, Xuehao
    Li, Xiangcheng
    Shu, Yongqian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
12345